Literature DB >> 10180677

Effects of user charges on the use of prescription medicines in different socio-economic groups.

L Lundberg1, M Johannesson, D G Isacson, L Borgquist.   

Abstract

This study examined the sensitivity towards increases in user charges for different types of drugs and among different socio-economic groups. It was based on responses by 2008 consumers of prescription drugs to a self-administered postal questionnaire sent to a random sample of 8000 inhabitants in Uppsala County in Sweden. The questionnaire included a question about whether the respondents would use fewer prescription drugs if the user charges increased by a specific amount. The increase in user charges was varied between 9 and 150% in five different subsamples. Logistic regression analysis was used to estimate the probability that a respondent would reduce consumption of prescription drugs as a function of the size of the user charges increase, socio-economic characteristics and the type of drug used. Results showed that the price sensitivity decreased with increasing age, income, education and self-rated health status. Price sensitivity was highest for antitussives and lowest for climacteric drugs. If the user charges doubled, 40% of antitussives users would reduce their consumption whereas only 11% of climacteric drugs users would reduce their consumption. It is concluded that sensitivity to increases in user charges varied greatly between different types of drugs and between socio-economic groups. The young, those with poor health status, low education and low income are most likely to decrease consumption of prescription drugs when user charges increase.

Mesh:

Year:  1998        PMID: 10180677     DOI: 10.1016/s0168-8510(98)00009-8

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  10 in total

1.  Recommended drug use after acute myocardial infarction by migration status and education level.

Authors:  Dashti Ali Mustafa Dzayee; Tahereh Moradi; Omid Beiki; Lars Alfredsson; Rickard Ljung
Journal:  Eur J Clin Pharmacol       Date:  2015-02-28       Impact factor: 2.953

2.  Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden.

Authors:  G Ringbäck Weitoft; O Ericsson; E Löfroth; M Rosén
Journal:  Eur J Clin Pharmacol       Date:  2008-01-06       Impact factor: 2.953

Review 3.  How does copayment for health care services affect demand, health and redistribution? A systematic review of the empirical evidence from 1990 to 2011.

Authors:  Astrid Kiil; Kurt Houlberg
Journal:  Eur J Health Econ       Date:  2013-08-29

4.  The impact of cost-sharing schemes on drug compliance in Italy: evidence based on quantile regression.

Authors:  Vincenzo Atella; Joanna Aleksandra Kopinska
Journal:  Int J Public Health       Date:  2013-12-15       Impact factor: 3.380

5.  Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada).

Authors:  Nadia Barozzi; Ingrid Sketris; Charmaine Cooke; Susan Tett
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

6.  Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs.

Authors:  Kristin Krigsman; Arne Melander; Anders Carlsten; Anders Ekedahl; J Lars Nilsson
Journal:  Pharm World Sci       Date:  2007-02

7.  Exploring the contexts, mechanisms and outcomes of a torture, abuse and dental anxiety service in Norway: a realist evaluation.

Authors:  Emilie Bryne; Sarah Catherine Patricia Duff Hean; Kjersti Berge Evensen; Vibeke Hervik Bull
Journal:  BMC Health Serv Res       Date:  2022-04-22       Impact factor: 2.908

8.  Differences in pharmaceutical consumption and expenses between immigrant and Spanish-born populations in Lleida, (Spain): a 6-months prospective observational study.

Authors:  Montserrat Rue; Maria-Catalina Serna; Jorge Soler-Gonzalez; Anna Bosch; Maria-Cristina Ruiz-Magaz; Leonardo Galvan
Journal:  BMC Health Serv Res       Date:  2008-02-06       Impact factor: 2.655

9.  What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Authors:  Marin C Gemmill; Sarah Thomson; Elias Mossialos
Journal:  Int J Equity Health       Date:  2008-05-02

10.  The abolition of user charges and the demand for ambulatory visits: evidence from the Czech Republic.

Authors:  Jana Votapkova; Pavlina Zilova
Journal:  Health Econ Rev       Date:  2016-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.